Lv1
46 积分 2023-03-09 加入
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis
39分钟前
待确认
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real‐world comparative study
3小时前
已完结
Clearance of Darier disease lesions in a patient with concomitant atopic dermatitis treated with abrocitinib
8天前
已完结
Real‐World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single‐Center Prospective Study
8天前
已完结
Blood transcriptome signature as indicator and predictor for efficacy of abrocitinib in treatment of atopic dermatitis
11天前
已完结
Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis
12天前
已完结
Switching from dupilumab to tralokinumab or Janus kinase inhibitors in cases of ocular and/or facial adverse events in patients with atopic dermatitis: a multicenter retrospective study
2个月前
已关闭
Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis
3个月前
已关闭
Multi-omic Approaches for Endotype Discovery in Allergy/Immunology
3个月前
已完结
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
4个月前
已完结
皖公网安备34019202002308
